7UPE | pdb_00007upe

Tau Paired Helical Filament from Alzheimer's Disease not incubated with EGCG


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.40 Å
  • Aggregation State: HELICAL ARRAY 
  • Reconstruction Method: HELICAL 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7UPE

This is version 1.1 of the entry. See complete history

Literature

Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in vitro.

Seidler, P.M.Murray, K.A.Boyer, D.R.Ge, P.Sawaya, M.R.Hu, C.J.Cheng, X.Abskharon, R.Pan, H.DeTure, M.A.Williams, C.K.Dickson, D.W.Vinters, H.V.Eisenberg, D.S.

(2022) Nat Commun 13: 5451-5451

  • DOI: https://doi.org/10.1038/s41467-022-32951-4
  • Primary Citation Related Structures: 
    7UPE, 7UPF, 7UPG

  • PubMed Abstract: 

    Alzheimer's disease (AD) is the consequence of neuronal death and brain atrophy associated with the aggregation of protein tau into fibrils. Thus disaggregation of tau fibrils could be a therapeutic approach to AD. The small molecule EGCG, abundant in green tea, has long been known to disaggregate tau and other amyloid fibrils, but EGCG has poor drug-like properties, failing to fully penetrate the brain. Here we have cryogenically trapped an intermediate of brain-extracted tau fibrils on the kinetic pathway to EGCG-induced disaggregation and have determined its cryoEM structure. The structure reveals that EGCG molecules stack in polar clefts between the paired helical protofilaments that pathologically define AD. Treating the EGCG binding position as a pharmacophore, we computationally screened thousands of drug-like compounds for compatibility for the pharmacophore, discovering several that experimentally disaggregate brain-derived tau fibrils in vitro. This work suggests the potential of structure-based, small-molecule drug discovery for amyloid diseases.


  • Organizational Affiliation
    • Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA.

Macromolecule Content 

  • Total Structure Weight: 459.2 kDa 
  • Atom Count: 5,680 
  • Modeled Residue Count: 740 
  • Deposited Residue Count: 4,410 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Isoform Tau-F of Microtubule-associated protein tau
A, B, C, D, E
A, B, C, D, E, F, G, H, I, J
441Homo sapiensMutation(s): 0 
UniProt & NIH Common Fund Data Resources
Find proteins for P10636 (Homo sapiens)
Explore P10636 
Go to UniProtKB:  P10636
PHAROS:  P10636
GTEx:  ENSG00000186868 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP10636
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.40 Å
  • Aggregation State: HELICAL ARRAY 
  • Reconstruction Method: HELICAL 
EM Software:
TaskSoftware PackageVersion
RECONSTRUCTIONRELION
MODEL REFINEMENTPHENIX

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute on Aging (NIH/NIA)United States1R01 AG029430
National Institutes of Health/National Institute on Aging (NIH/NIA)United StatesAG061847
National Institutes of Health/National Institute on Aging (NIH/NIA)United StatesRF1 AG054022
National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States1F32 NS095661

Revision History  (Full details and data files)

  • Version 1.0: 2022-09-28
    Type: Initial release
  • Version 1.1: 2024-06-12
    Changes: Data collection, Refinement description